Last reviewed · How we verify

NCT06251271

Diagnosing Obstructive Lung Disease With Point of Care Ultrasound

Completed Last updated 30 July 2024
What this trial tests

trial testing Point-of-Care Ultrasound in Pulmonary Disease, Chronic Obstructive in 301 participants. Completed in 27 July 2024.

Timeline
1 August 2023
Primary endpoint
1 July 2024
27 July 2024

Quick facts

Lead sponsorSoroka University Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment301
Start date1 August 2023
Primary completion1 July 2024
Estimated completion27 July 2024
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Soroka University Medical Center

Who can join

18 and older, any sex, with Pulmonary Disease, Chronic Obstructive or Lung Diseases, Obstructive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the diagnostic accuracy of Point of Care Ultrasound (POCUS) in identifying obstructive lung diseases (OLDs), using pulmonary function tests (PFTs) as the gold standard for comparison.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Point-of-Care Ultrasound

Trials testing the same drug.

Other recruiting trials for Pulmonary Disease, Chronic Obstructive

Currently open trials in the same condition.

Other Soroka University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06251271.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing